Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
Status: Enrolling
Updated:  12/31/1969
Swedish Organ Transplant and Liver Center
mi
from
Seattle, WA
Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
Status: Enrolling
Updated: 12/31/1969
Swedish Organ Transplant and Liver Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
mi
from
Seattle, WA
Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Isoflavones for Promoting Calcium Absorption and Preventing Bone Loss in Post Menopausal Women
Metabolism and Bone Health
Status: Enrolling
Updated:  12/31/1969
Purdue University
mi
from
West Lafayette, IN
Isoflavones for Promoting Calcium Absorption and Preventing Bone Loss in Post Menopausal Women
Metabolism and Bone Health
Status: Enrolling
Updated: 12/31/1969
Purdue University
mi
from
West Lafayette, IN
Click here to add this to my saved trials
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Status: Enrolling
Updated:  12/31/1969
University of California-Irvine/VA Medical Center-Long Beach
mi
from
Long Beach, CA
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Status: Enrolling
Updated: 12/31/1969
University of California-Irvine/VA Medical Center-Long Beach
mi
from
Long Beach, CA
Click here to add this to my saved trials
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Status: Enrolling
Updated:  12/31/1969
USC School of Medicine
mi
from
Los Angeles, CA
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Status: Enrolling
Updated: 12/31/1969
USC School of Medicine
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Status: Enrolling
Updated:  12/31/1969
UCHSC (University of Colorado)
mi
from
Denver, CO
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Status: Enrolling
Updated: 12/31/1969
UCHSC (University of Colorado)
mi
from
Denver, CO
Click here to add this to my saved trials
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Status: Enrolling
Updated:  12/31/1969
University of Connecticut Health Center
mi
from
Farmington, CT
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Status: Enrolling
Updated: 12/31/1969
University of Connecticut Health Center
mi
from
Farmington, CT
Click here to add this to my saved trials
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Status: Enrolling
Updated:  12/31/1969
Lds, Niddk, Nih
mi
from
Bethesda, MD
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Status: Enrolling
Updated: 12/31/1969
Lds, Niddk, Nih
mi
from
Bethesda, MD
Click here to add this to my saved trials
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Status: Enrolling
Updated:  12/31/1969
UMass Memorial HealthCare, University Campus
mi
from
Worcester, MA
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Status: Enrolling
Updated: 12/31/1969
UMass Memorial HealthCare, University Campus
mi
from
Worcester, MA
Click here to add this to my saved trials
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Status: Enrolling
Updated:  12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Status: Enrolling
Updated:  12/31/1969
Saint Louis University
mi
from
Saint Louis, MO
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Status: Enrolling
Updated: 12/31/1969
Saint Louis University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern-Dallas
mi
from
Dallas, TX
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern-Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Status: Enrolling
Updated:  12/31/1969
Medical College of Virginia
mi
from
Richmond, VA
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Status: Enrolling
Updated: 12/31/1969
Medical College of Virginia
mi
from
Richmond, VA
Click here to add this to my saved trials
A Study of LY3314814 in Participants With Liver Impairment
Pharmacokinetics of LY3314814 in Subjects With Hepatic Impairment
Status: Enrolling
Updated:  12/31/1969
Orange County Research Center
mi
from
Tustin, CA
A Study of LY3314814 in Participants With Liver Impairment
Pharmacokinetics of LY3314814 in Subjects With Hepatic Impairment
Status: Enrolling
Updated: 12/31/1969
Orange County Research Center
mi
from
Tustin, CA
Click here to add this to my saved trials
A Study of LY3314814 in Participants With Liver Impairment
Pharmacokinetics of LY3314814 in Subjects With Hepatic Impairment
Status: Enrolling
Updated:  12/31/1969
Clinical Pharmacology of Miami
mi
from
Miami, FL
A Study of LY3314814 in Participants With Liver Impairment
Pharmacokinetics of LY3314814 in Subjects With Hepatic Impairment
Status: Enrolling
Updated: 12/31/1969
Clinical Pharmacology of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of LY3314814 in Participants With Liver Impairment
Pharmacokinetics of LY3314814 in Subjects With Hepatic Impairment
Status: Enrolling
Updated:  12/31/1969
Orlando Clinical Research Center
mi
from
Orlando, FL
A Study of LY3314814 in Participants With Liver Impairment
Pharmacokinetics of LY3314814 in Subjects With Hepatic Impairment
Status: Enrolling
Updated: 12/31/1969
Orlando Clinical Research Center
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study of LY3314814 in Participants With Liver Impairment
Pharmacokinetics of LY3314814 in Subjects With Hepatic Impairment
Status: Enrolling
Updated:  12/31/1969
New Orleans Cntr for Clin Res
mi
from
Knoxville, TN
A Study of LY3314814 in Participants With Liver Impairment
Pharmacokinetics of LY3314814 in Subjects With Hepatic Impairment
Status: Enrolling
Updated: 12/31/1969
New Orleans Cntr for Clin Res
mi
from
Knoxville, TN
Click here to add this to my saved trials
Analysis and Characterization of Biologic Implants
Analysis and Characterization of in Vivo Tissue Remodeling in Routine Biologic Mesh Explants From Patients Undergoing Reoperation for Recurrent Hernia or Revision of a Prior Surgical Site
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Analysis and Characterization of Biologic Implants
Analysis and Characterization of in Vivo Tissue Remodeling in Routine Biologic Mesh Explants From Patients Undergoing Reoperation for Recurrent Hernia or Revision of a Prior Surgical Site
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
The Biologic Basis of Hernia Formation
The Biologic Basis of Hernia Formation
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
The Biologic Basis of Hernia Formation
The Biologic Basis of Hernia Formation
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1
Treatment of Adult ADHD in Methadone Patients
Status: Enrolling
Updated:  12/31/1969
Research Foundation for Mental Hygiene, Inc.
mi
from
New York, NY
Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1
Treatment of Adult ADHD in Methadone Patients
Status: Enrolling
Updated: 12/31/1969
Research Foundation for Mental Hygiene, Inc.
mi
from
New York, NY
Click here to add this to my saved trials
HIV Counseling Intervention for Methadone-Maintained Patients - 2
HIV Counseling Intervention for Methadone-Maintained Patients
Status: Enrolling
Updated:  12/31/1969
Research Foundation for Mental Hygiene, Inc.
mi
from
New York, NY
HIV Counseling Intervention for Methadone-Maintained Patients - 2
HIV Counseling Intervention for Methadone-Maintained Patients
Status: Enrolling
Updated: 12/31/1969
Research Foundation for Mental Hygiene, Inc.
mi
from
New York, NY
Click here to add this to my saved trials
Myfortic, Prograf, and Corticosteroids in de Novo Liver Transplantation
An Open-label Study of the Pharmacokinetics of Mycophenolic Acid as Myfortic (Enteric-coated Mycophenolate Sodium) When Used in Combination With Prograf (Tacrolimus) and Corticosteroids in Patients Undergoing de Novo Liver Transplantation
Status: Enrolling
Updated:  12/31/1969
Methodist Hospital System
mi
from
Houston, TX
Myfortic, Prograf, and Corticosteroids in de Novo Liver Transplantation
An Open-label Study of the Pharmacokinetics of Mycophenolic Acid as Myfortic (Enteric-coated Mycophenolate Sodium) When Used in Combination With Prograf (Tacrolimus) and Corticosteroids in Patients Undergoing de Novo Liver Transplantation
Status: Enrolling
Updated: 12/31/1969
Methodist Hospital System
mi
from
Houston, TX
Click here to add this to my saved trials
Dermagraft(R) for the Treatment of Patients With Diabetic Foot Ulcers
A Prospective, Multicenter, Randomized, Single-Blind Clinical Investigation of Dermagraft(R) in Patients With Plantar Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
Richard Pollak, DPM
mi
from
San Antonio, TX
Dermagraft(R) for the Treatment of Patients With Diabetic Foot Ulcers
A Prospective, Multicenter, Randomized, Single-Blind Clinical Investigation of Dermagraft(R) in Patients With Plantar Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Richard Pollak, DPM
mi
from
San Antonio, TX
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Diabetic Foot Ulcers
A Prospective, Multicenter, Randomized, Single-Blind, Phase III, Clinical Investigation of Dermagraft(R) in Patients With Plantar Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
University of North Carolina School of Medicine
mi
from
Chapel Hill, NC
Pivotal Trial of Dermagraft(R) to Treat Diabetic Foot Ulcers
A Prospective, Multicenter, Randomized, Single-Blind, Phase III, Clinical Investigation of Dermagraft(R) in Patients With Plantar Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
University of North Carolina School of Medicine
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Dose Effect Relationship of MTX and IBD
Dose Effect Relationship of Methotrexate and Hepatic Fibrosis in Patients With Inflammatory Bowel Disease
Status: Enrolling
Updated:  12/31/1969
Children's Mercy Hospital
mi
from
Kansas City, MO
Dose Effect Relationship of MTX and IBD
Dose Effect Relationship of Methotrexate and Hepatic Fibrosis in Patients With Inflammatory Bowel Disease
Status: Enrolling
Updated: 12/31/1969
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Dose-Optimization Trial of VXA-G1.1-NN in Healthy Volunteers
A Phase 1b, Open-Label, Dose-Optimization Trial of an Adenoviral-vector Based Norovirus Vaccine (VXA-G1.1-NN) Expressing GI.1 VP1 and dsRNA Adjuvant Administered Orally to Healthy Volunteers
Status: Enrolling
Updated:  12/31/1969
Celerion
mi
from
Lincoln, NE
Dose-Optimization Trial of VXA-G1.1-NN in Healthy Volunteers
A Phase 1b, Open-Label, Dose-Optimization Trial of an Adenoviral-vector Based Norovirus Vaccine (VXA-G1.1-NN) Expressing GI.1 VP1 and dsRNA Adjuvant Administered Orally to Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Celerion
mi
from
Lincoln, NE
Click here to add this to my saved trials
A Pilot, Dose Escalating Study on VLX103 in Moderate Alcoholic Steatohepatitis
A Pilot, Exploratory Dose Escalating Study on the Safety, Pharmacodynamics and Preliminary Efficacy of VLX103 in the Treatment of Moderate Alcoholic Steatohepatitis
Status: Enrolling
Updated:  12/31/1969
UMass Medical School
mi
from
Worcester, MA
A Pilot, Dose Escalating Study on VLX103 in Moderate Alcoholic Steatohepatitis
A Pilot, Exploratory Dose Escalating Study on the Safety, Pharmacodynamics and Preliminary Efficacy of VLX103 in the Treatment of Moderate Alcoholic Steatohepatitis
Status: Enrolling
Updated: 12/31/1969
UMass Medical School
mi
from
Worcester, MA
Click here to add this to my saved trials
Phase 1 Placebo-controlled, Randomized Trial of an Adenoviral-vector Based Norovirus Vaccine
A Phase 1, Randomized, Double-Blind, Placebo-controlled, Dose-ranging Trial to Determine the Safety and Immunogenicity of an Adenoviral-vector Based Norovirus Vaccine (VXA‑G1.1-NN) Expressing GI.1 VP1 and dsRNA Adjuvant Administered Orally to Healthy Volunteers
Status: Enrolling
Updated:  12/31/1969
Celerion
mi
from
Lincoln, NE
Phase 1 Placebo-controlled, Randomized Trial of an Adenoviral-vector Based Norovirus Vaccine
A Phase 1, Randomized, Double-Blind, Placebo-controlled, Dose-ranging Trial to Determine the Safety and Immunogenicity of an Adenoviral-vector Based Norovirus Vaccine (VXA‑G1.1-NN) Expressing GI.1 VP1 and dsRNA Adjuvant Administered Orally to Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Celerion
mi
from
Lincoln, NE
Click here to add this to my saved trials
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Salt Lake City, UT
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Pasadena, CA
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Pasadena, CA
Click here to add this to my saved trials
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Pottsville, PA
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Pottsville, PA
Click here to add this to my saved trials
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Jacksonville, FL
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Margate, FL
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Margate, FL
Click here to add this to my saved trials
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Ames, IA
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Ames, IA
Click here to add this to my saved trials
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Las Vegas, NV
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Manhasset, NY
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Manhasset, NY
Click here to add this to my saved trials
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Winston-Salem, NC
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Pittsburgh, PA
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Knoxville, TN
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Knoxville, TN
Click here to add this to my saved trials
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Houston, TX
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Houston, TX
Click here to add this to my saved trials
AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers
A Prospective, Multi-Center, Randomized, Parallel-group Study Comparing AMNIOEXCEL Plus Placental Allograft Membrane to a Marketed Comparator and Standard of Care Procedures in the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
California 1
mi
from
Fresno, CA
AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers
A Prospective, Multi-Center, Randomized, Parallel-group Study Comparing AMNIOEXCEL Plus Placental Allograft Membrane to a Marketed Comparator and Standard of Care Procedures in the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
California 1
mi
from
Fresno, CA
Click here to add this to my saved trials
AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers
A Prospective, Multi-Center, Randomized, Parallel-group Study Comparing AMNIOEXCEL Plus Placental Allograft Membrane to a Marketed Comparator and Standard of Care Procedures in the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
California 2
mi
from
Los Angeles, CA
AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers
A Prospective, Multi-Center, Randomized, Parallel-group Study Comparing AMNIOEXCEL Plus Placental Allograft Membrane to a Marketed Comparator and Standard of Care Procedures in the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
California 2
mi
from
Los Angeles, CA
Click here to add this to my saved trials
AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers
A Prospective, Multi-Center, Randomized, Parallel-group Study Comparing AMNIOEXCEL Plus Placental Allograft Membrane to a Marketed Comparator and Standard of Care Procedures in the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
New Jersey 1
mi
from
Toms River, NJ
AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers
A Prospective, Multi-Center, Randomized, Parallel-group Study Comparing AMNIOEXCEL Plus Placental Allograft Membrane to a Marketed Comparator and Standard of Care Procedures in the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
New Jersey 1
mi
from
Toms River, NJ
Click here to add this to my saved trials
AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers
A Prospective, Multi-Center, Randomized, Parallel-group Study Comparing AMNIOEXCEL Plus Placental Allograft Membrane to a Marketed Comparator and Standard of Care Procedures in the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
Texas 1
mi
from
San Antonio, TX
AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers
A Prospective, Multi-Center, Randomized, Parallel-group Study Comparing AMNIOEXCEL Plus Placental Allograft Membrane to a Marketed Comparator and Standard of Care Procedures in the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Texas 1
mi
from
San Antonio, TX
Click here to add this to my saved trials
AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers
A Prospective, Multi-Center, Randomized, Parallel-group Study Comparing AMNIOEXCEL Plus Placental Allograft Membrane to a Marketed Comparator and Standard of Care Procedures in the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
Georgia 1
mi
from
Gainesville, GA
AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers
A Prospective, Multi-Center, Randomized, Parallel-group Study Comparing AMNIOEXCEL Plus Placental Allograft Membrane to a Marketed Comparator and Standard of Care Procedures in the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Georgia 1
mi
from
Gainesville, GA
Click here to add this to my saved trials
AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers
A Prospective, Multi-Center, Randomized, Parallel-group Study Comparing AMNIOEXCEL Plus Placental Allograft Membrane to a Marketed Comparator and Standard of Care Procedures in the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
Illinois 1
mi
from
Springfield, IL
AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers
A Prospective, Multi-Center, Randomized, Parallel-group Study Comparing AMNIOEXCEL Plus Placental Allograft Membrane to a Marketed Comparator and Standard of Care Procedures in the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Illinois 1
mi
from
Springfield, IL
Click here to add this to my saved trials
AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers
A Prospective, Multi-Center, Randomized, Parallel-group Study Comparing AMNIOEXCEL Plus Placental Allograft Membrane to a Marketed Comparator and Standard of Care Procedures in the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
California 3
mi
from
Fresno, CA
AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers
A Prospective, Multi-Center, Randomized, Parallel-group Study Comparing AMNIOEXCEL Plus Placental Allograft Membrane to a Marketed Comparator and Standard of Care Procedures in the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
California 3
mi
from
Fresno, CA
Click here to add this to my saved trials
A Study to Evaluate Seladelpar in Subjects With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Activity of Seladelpar in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
CymaBay Research Site
mi
from
Glendale, AZ
A Study to Evaluate Seladelpar in Subjects With Nonalcoholic Steatohepatitis (NASH)
A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Activity of Seladelpar in Subjects With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
CymaBay Research Site
mi
from
Glendale, AZ
Click here to add this to my saved trials